Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies

Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients

NCT02956772 ·Status: UNKNOWN ·Phase: PHASE2

HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival

NCT07277192 ·Status: COMPLETED

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma

NCT02150317 ·Status: UNKNOWN ·Phase: NA

Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma

NCT07204262 ·Status: COMPLETED

Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma

NCT00493402 ·Status: COMPLETED ·Phase: PHASE3

TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma

NCT04559607 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment

NCT07100405 ·Status: RECRUITING

TACE Combined With Penpulimab and Anlotinib for Advanced HCC

NCT05344924 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

NCT02631499 ·Status: UNKNOWN ·Phase: PHASE4

Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma

NCT02584556 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma

NCT02038296 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

NCT04975932 ·Status: COMPLETED

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

NCT06669377 ·Status: RECRUITING

Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma

NCT03066557 ·Status: UNKNOWN ·Phase: NA

Survival Analysis: TACE vs. Combination Therapy in HCC

NCT06261138 ·Status: COMPLETED

Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)

NCT01170104 ·Status: UNKNOWN ·Phase: PHASE2

EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial

NCT07187284 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma

NCT02529761 ·Status: UNKNOWN ·Phase: NA

TACE Combined With PD-1 Knockout Engineered T Cell in Advanced Hepatocellular Carcinoma.

NCT04417764 ·Status: UNKNOWN ·Phase: PHASE1

DEB-TACE+HAIC vs. HAIC for Large HCC

NCT05263219 ·Status: RECRUITING ·Phase: PHASE3

TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC

NCT03782831 ·Status: WITHDRAWN ·Phase: PHASE2

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma

NCT05717738 ·Status: RECRUITING

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

NCT06205732 ·Status: RECRUITING

The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)

NCT04517227 ·Status: NOT_YET_RECRUITING ·Phase: NA

Sorafenib Chemoembolization Evaluation Controlled Trial

NCT01906216 ·Status: COMPLETED ·Phase: PHASE3